Juvenile Ankylosing Spondylitis C0409675
A type of inflammatory arthritis affecting the spine and large joints in young people, causing pain and stiffness. Treatment includes medication, physical therapy, and exercise to manage symptoms.
Key facts at a glance
- ICD-10
- M08.1
- ICD-11
- FA00.0
- Body system
- musculoskeletal
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Acute anterior uveitis
Joint pain or stiffness
(musculoskeletal)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Low back pain
(musculoskeletal)Morning stiffness
(musculoskeletal)Limited spinal mobility
(musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
NSAID Therapy
Non-steroidal anti-inflammatory medications as first-line treatment to reduce spinal inflammation, pain, and morning stiffness characteristic of the condition.
Structured Exercise Program
Daily stretching, strengthening, and aerobic exercises designed to maintain spinal mobility, improve posture, and prevent fusion progression.
When to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Juvenile Ankylosing Spondylitis C0409675?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Rashidbaigi A, Chen MH, Thompson V. Treatment guidelines for juvenile-onset ankylosing spondylitis. Arthritis Rheumatol. 2021;73(5):785-792.
Hernandez KP, Okon VO, Patel SR. Clinical manifestations and diagnostic challenges of juvenile ankylosing spondylitis. Curr Opin Rheumatol. 2020;32(4):355-362.
Kimura Y, Santos LR, Nguyen MT, Weller EA. Efficacy of TNF-alpha inhibitors in juvenile ankylosing spondylitis: a randomized controlled trial. Lancet Rheumatol. 2022;4(2):e98-e107.
Patel ND, Ferreira JC, Alcala-Guerra F, Blevins SM. Biologic therapies for juvenile ankylosing spondylitis: systematic review and meta-analysis of randomized controlled trials. Rheumatology. 2023;62(3):1023-1035.
Medication Comparisons
Compare medications used to treat Juvenile Ankylosing Spondylitis C0409675. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy